[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-PYXS":3,"homepage-market-summary":30,"stock-news-PYXS":171},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"PYXS","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Pyxis Oncology, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.","56","Boston, MA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":17,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},2.01,2.02,2.086,2,-0.01,-0.5,951885.809245,5768,2.0264,5.55,1.03,976227.2408188247,21.7,1254,{"status":31,"indices":32,"watchlist":75,"sectors":97,"benchmarks":151},"success",[33,40,47,54,60,67],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":14,"sparkline":39,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":14,"sparkline":46,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":14,"sparkline":53,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":38,"is_up":14,"sparkline":59,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":61,"name":62,"price":63,"change":64,"pct_change":65,"is_up":14,"sparkline":66,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":72,"is_up":73,"sparkline":74,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[76,83,90],{"symbol":77,"name":78,"price":79,"change":80,"pct_change":81,"is_up":14,"sparkline":82,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":84,"name":85,"price":86,"change":87,"pct_change":88,"is_up":73,"sparkline":89,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":14,"sparkline":96,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[98,103,108,112,117,122,127,132,137,141,146],{"name":99,"etf":100,"change":101,"price":102,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":104,"etf":105,"change":106,"price":107,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":109,"etf":110,"change":26,"price":111,"is_up":73},"Healthcare","XLV",168.81,{"name":113,"etf":114,"change":115,"price":116,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":118,"etf":119,"change":120,"price":121,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":123,"etf":124,"change":125,"price":126,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":128,"etf":129,"change":130,"price":131,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":133,"etf":134,"change":135,"price":136,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":138,"etf":139,"change":65,"price":140,"is_up":14},"Real Estate","XLRE",40.57,{"name":142,"etf":143,"change":144,"price":145,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":147,"etf":148,"change":149,"price":150,"is_up":14},"Comm Services","XLC",-0.35,111.26,[152,157,162,167],{"ticker":153,"name":154,"price":155,"change":156,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":158,"name":159,"price":160,"change":161,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":163,"name":164,"price":165,"change":166,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":168,"name":169,"price":170,"change":65,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":172,"articles":173},20,[174,180,186,192,198,204,210,216,222,228,234,239,244,249,254,260,265,270,275,281],{"title":175,"link":176,"pubDate":177,"description":178,"source":179},"PYXS Stock Price, Quote & Chart - ChartMill","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiX0FVX3lxTE5oOENVQ3p2eWtBcV84MTg2bS1SbmsxT3Y3S25sMzk4N1hXd2hyS1NvZ3VBMzJsNV9GNnloNll4aTJDYU4zVjNpbnVleU1NU0wxUmR4YUQzcVh4VTkzUVE0?oc=5","Fri, 02 Oct 2026 07:00:00 GMT","PYXS Stock Price, Quote & Chart ChartMill","ChartMill",{"title":181,"link":182,"pubDate":183,"description":184,"source":185},"Latham Advises on Pyxis Oncology’s Up to US$282.6 Million Public Offering - Latham & Watkins LLP","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiiwFBVV95cUxNa0RLb2F0Mk5VdWZnSXNJb2ZKMG9nVC1COTF2MWZqN1BXTXRhckhMX3hXWmhQdGFkSWFMSkxmY3ZkY1JYYWJiR3VjSVNoRm44RWZTUk43SFdlaUFiY0dXWW1ZYkh2Z2pmRF9aY3RzdXppVXpjaEg1ZFVHU0VSdGl4LWthYWszbVJDY0pv?oc=5","Wed, 30 Sep 2026 18:20:29 GMT","Latham Advises on Pyxis Oncology’s Up to US$282.6 Million Public Offering Latham & Watkins LLP","Latham & Watkins LLP",{"title":187,"link":188,"pubDate":189,"description":190,"source":191},"Pyxis Oncology stock falls on public offering announcement - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiigFBVV95cUxQb2ZudEFOaU1nLWM5Z0Npb2lEWThGYUNIbHRic3pSazV4WGlBVkZqQ0tLLTVQQlY3dU5fSVV3QUUyUWJqaDFQZnR1aUYwcjdBSXF3UGFXbnlPYWlCbi1JUlBHUHpIY2NsaDA2U0VaVVVBTmdQREpiNnhmOHg0YVZCdEJCNUdxbV9obnc?oc=5","Tue, 29 Sep 2026 21:22:09 GMT","Pyxis Oncology stock falls on public offering announcement Yahoo Finance UK","Yahoo Finance UK",{"title":193,"link":194,"pubDate":195,"description":196,"source":197},"A 10% owner buys $2.90 share-and-warrant packages in Pyxis Oncology (PYXS). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxOX2JnN1NxWFJrZTF4ODUzVlZmcHBJLV9VbDR2RTFiaTFJSGpGUFFTaU5uS1llS3lvVzJiWVVsOGN6LXl6TU9IN0ZJcERsR0RLcmhYdjlCRWVNdEtQUE1ReGxlX3NycFlpT29wQjJLMnFIUUpWOXJBRFNDZ2Q1U1BRNWtHU1RETVRsQmZiUzJNbVNoTU9pUF9PSENuYzBHY3JFOHdBaXZOc1Q1Snd1ZTNkeXN3?oc=5","Fri, 02 Oct 2026 12:35:58 GMT","A 10% owner buys $2.90 share-and-warrant packages in Pyxis Oncology (PYXS). Stock Titan","Stock Titan",{"title":199,"link":200,"pubDate":201,"description":202,"source":203},"Pyxis Oncology shares slide after pricing $110M registered public offering - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0gFBVV95cUxOVXhaVjNqZFpyZHNwSTVoSzZsODlickNWZk9ETEEtZ3o1ZjB0LWI1aDBRZEtZSF9HbkVvY2FzcUJvRXVJU2RTNkVydW9Fak1maWNwdE01SU0wYXp2MHRNNm9MTllrRWpKSFJXMHBpZlBHT1dxcGZibU9wVGxuZGlrSzZfM1RyMTBJY19YTDZjQVlzQUhDUnhLMjVpYjdhZ3RacjlZT2VUdVFQVnJTZk9rdG1hbnJ3dFhhSUNBNHZ2RXRLdloyak1zaHpjaXhneVdlN1E?oc=5","Wed, 30 Sep 2026 06:16:00 GMT","Pyxis Oncology shares slide after pricing $110M registered public offering TradingView","TradingView",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"Pyxis Oncology Announces Proposed Registered Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5wFBVV95cUxQT29fTXVmRkVMTzRLU1BsdEx0endfNWlUNnVKdjVTcUFHSG5LMllyNldFOVdQd29iYXhSN3lWY1Z4WmEzWTd3aW1rRU9VRE02MHpyQVhTQ0t0Um01QzFNNEJObkZTWkw2Y3hTbWF5TFc3UVhqdGQ0N2IzSzF0dEdiWVR5SnpaUWlXWEZrMVJqQXk0Y2FfVnVrbWhKLUk5dWI3NjREcXVxa2s5NmxpVzV0bHJpSEpSbmFkRW5ZMEZ4dW9QZm40eW9NTEUxLTBDbnBvcFV3ckdwaXRhXzRBYWZkQVczLTRPU0k?oc=5","Tue, 29 Sep 2026 20:30:00 GMT","Pyxis Oncology Announces Proposed Registered Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants Quiver Quantitative","Quiver Quantitative",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"Biggest stock movers Wednesday: BA, PYXS, NOC, and more (NOC:NYSE) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikwFBVV95cUxONjFXdldIVUJydElJc2hVNXdnN1BwbGE4akhPeTM3VkxIN3JpWnlnQjc2cHFLdkZjU3ZJdWlFWTdpek9vM1p1QW1BdHRGcWZ0U3ktZnJqcllHOVpPa1p1dTFJeGhTcnluTFJsMkozTENWaUJzemxEQXpuZ2JxbjdFcjZENV9ySGdqMlRFbS1hQ2lLR1U?oc=5","Wed, 30 Sep 2026 09:08:22 GMT","Biggest stock movers Wednesday: BA, PYXS, NOC, and more (NOC:NYSE) Seeking Alpha","Seeking Alpha",{"title":217,"link":218,"pubDate":219,"description":220,"source":221},"Pyxis Oncology Prices Public Offering of Common Stock, Warrants - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxPcjRYc2RodFdTN2poX3ZlbkZVVTZ1UjNjYlZrUWhhdDkwdEFGNG1BRTc4azBlZjg5YmZRbEYxWnRkaUE5Q3lfTG9oQWVSaTlSdmt2Rzg1dXpVTWgzblltdWVBRmJtR2VZcFF3UHFOb1dZdzJ5eVk4UExFbGpmd2hfTmNkMjhlRm5uQ2k5RGxCSkp2OG84UEh2aGduWnluOE1IUElTTw?oc=5","Wed, 30 Sep 2026 07:58:08 GMT","Pyxis Oncology Prices Public Offering of Common Stock, Warrants Yahoo Finance","Yahoo Finance",{"title":223,"link":224,"pubDate":225,"description":226,"source":227},"Pyxis Oncology Prices Public Offering of Common Stock, Warrants - marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitgFBVV95cUxNZDNUMzlGc05RWnBkRzJnaVdlcG9XTmpLQ0pYSjVQT2QyTW94eGNURlBFNm9Pa3hYQm05TmRYZmd5ZzZnN2U2bFhSWmhWVU1uX0lHR1Fia0xQdWZRNHlwd0p3cDhTbkRzQ29rRF93R3BORFRzSEpFLVVRRTVqSko3SzQtbXYyQzE2c2VfMUNuYmVKdVpzbEZlNDlyaG5Ba1gybDRhUnQxZE9BM3ZFX3RhRkRqQUMyZw?oc=5","Wed, 30 Sep 2026 07:59:24 GMT","Pyxis Oncology Prices Public Offering of Common Stock, Warrants marketscreener.com","marketscreener.com",{"title":229,"link":230,"pubDate":231,"description":232,"source":233},"Pyxis Oncology Inc (PYXS) Key Financial Ratios – Valuation, Profitability & More - Value Research","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijgFBVV95cUxNSENYVk5nYUFXdWRyUW9PQ29jNXZYdUQ4Si03S0xGb2d2Mmp6SVhxYk1vcGFSLWNwRFQ0ZUk0cy0yOEllZVZhVVcyQUY5bG15aWMtVE05MGRsRnM2N0ZRMzRjQ2tZWkhHWGJnVjgzX244bDZRT0tjSnp2ajJPSEI5aU5faHlxY1NOXzBqWG1R?oc=5","Tue, 29 Sep 2026 20:29:00 GMT","Pyxis Oncology Inc (PYXS) Key Financial Ratios – Valuation, Profitability & More Value Research","Value Research",{"title":235,"link":236,"pubDate":237,"description":238,"source":197},"An ownership cap restricts warrant exercise for a Pyxis Oncology (PYXS) investor. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxNaU5oX3BzdHJrNGFQWDJBNTQzVGttUXR4ZWhyWHNPckU3T05GeXRocDQ5OG84bUpIa0hOdkN2bWpPSHV5UGVwTDBoNXlVXzdDY1BHRnRUZ2hOX0paTGpCRjgtVXRYTHZhaVlFWm90S05aaHZGc2oycU1tM1VZcjV4alJNU3NOUzB0V0prNzMwTmN0WWYzc2trVHpCcnU5WlN6S1F5R1JfLXRMS1lCSWRtVWhONzdVQXB5SFNGaHQ5RkZ2NVRNeUMzUVBsSQ?oc=5","Fri, 02 Oct 2026 12:34:59 GMT","An ownership cap restricts warrant exercise for a Pyxis Oncology (PYXS) investor. Stock Titan",{"title":240,"link":241,"pubDate":242,"description":243,"source":215},"Pyxis Oncology: Better Runway Is Bullish For MICVO’s Remaining R&D (NASDAQ:PYXS) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxORWlzb1ZSbEJ2VXllNTMwYks1QmcwWWRTQXNkQ1J2TnJCYmFOQ09HV2lyLXNDZS1ZaTZrMUNGZ0xCMXJHeUxoVWdnaGlEVHdvVDU4am1TNUlsZHc2VFZfZTgwWVJkNGlycmdnT2wxZ3F1T1JZQ1F4QUx6WkkzcW41S001V3BvZE00eThhZExKd1RPQzBwMmEzWEVZT0FkclkwWXJ1Q2FyUGg3RElmTWpfdXZn?oc=5","Sun, 04 Oct 2026 13:30:37 GMT","Pyxis Oncology: Better Runway Is Bullish For MICVO’s Remaining R&D (NASDAQ:PYXS) Seeking Alpha",{"title":245,"link":246,"pubDate":247,"description":248,"source":209},"Pyxis Oncology Closes $110 Million Public Offering to Advance MICVO Clinical Development - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxQc3kzSEJlbHlydUdaY1o2VU1EWnNMaGlDU1hBY2lSRzFYVTg1Z2FEQlR3cVdEcXZHeGJXV2dyZU9HWHFwVUdFbUUwTjBBeENSN1hvc1RGQVNxNGZ2aE13YXk0ZEJmUWtFOC1mMVpNYVBDTzZFRmNfV3VqZFJVQlJJcVBUZ3kzNTR2Vm9CUm0xc09SM2RSbW4wTmkxQk44Uk0xN01RUkR0M3gwNUcwY1llVVk4YWw2Ulo0SEQwZnpB?oc=5","Fri, 02 Oct 2026 11:10:00 GMT","Pyxis Oncology Closes $110 Million Public Offering to Advance MICVO Clinical Development Quiver Quantitative",{"title":250,"link":251,"pubDate":252,"description":253,"source":203},"Pyxis Oncology launches offering for phase 3 cancer trial; stock tumbles - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizwFBVV95cUxNTHRsVGtTMEVQYklYMDVoMGVjMy14OW96cU9uVjg4OHViY2liNXBVQjB4OTQtSnJQRmFYXzNRVGNScnBCY0Z4QzBsdVpNLTh6WW1ZLWpDYlN6dGlRTTRXTl9RN1pIdHdlWjB5QTdsREtpa0hUMXF2OGcxUjlYY1ZIMy10TjBFUWgtcnNrdmdyZHNxVnRXaGZqcmFNYWZBZG5HSEpoZjhVQzRoeEVxR3UxVXlxMXhTdFJNNUw3V2xTZ1hvbldnYVRrM0UzSFJidFU?oc=5","Tue, 29 Sep 2026 20:42:28 GMT","Pyxis Oncology launches offering for phase 3 cancer trial; stock tumbles TradingView",{"title":255,"link":256,"pubDate":257,"description":258,"source":259},"Pyxis Oncology launches public offering of stock and warrants By Investing.com - Investing.com Nigeria","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxPbTA5bXllNFBBUjJMVjN1RUFyVFdSSFZobnEySjFySHJ1c0xWYVBpSXhHdEFqT2N4MDJUeEY5YlBMZFRHNlh1c1cwanpSeEVSSFgxd0JHeWJrRk91bjBYMlhrNUZlTmZBel9JdlR4VkVvaFFkWnFaRkV2ZTZldmR5dVF5S1hYRVZOLXhfYkN4UW4zcWJhSHBpWWRxVE42aEFpLWk1NVdwUk5IN0F4bTFDR3FHVkxKYjZPeWJEXzNYRQ?oc=5","Tue, 29 Sep 2026 21:06:44 GMT","Pyxis Oncology launches public offering of stock and warrants By Investing.com Investing.com Nigeria","Investing.com Nigeria",{"title":261,"link":262,"pubDate":263,"description":264,"source":197},"A passive holder reports over 5% of Pyxis Oncology (PYXS), with some warrants excluded. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxQcG9uZWxJX1pVdXRvR2oxcEFPYmJrcWxOb2h2SzdZR3hpNXYtYWVCcHR0dEZON2J3dWV4NUhTTTdqR0NkYUlVWlROaHZxSWJWZVdjNVN0WmVrN0xxNXJhT3JfdDBnSHFwRE5FaE93Z1ozbmQyanpzSTVuTGhSR2tZeHg4Sm0zczl6VE0tYVpmeGtVQlVObnJQUXFGUW93MVJrWlRwcWZBWWpvVzVIYzNVQ2F5R1lHT2VMYTV2VWJlNU5yUTg?oc=5","Mon, 05 Oct 2026 14:26:28 GMT","A passive holder reports over 5% of Pyxis Oncology (PYXS), with some warrants excluded. Stock Titan",{"title":266,"link":267,"pubDate":268,"description":269,"source":259},"Pyxis Oncology closes $110 million public offering By Investing.com - Investing.com Nigeria","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwFBVV95cUxNMDBpSVp1dGFJel9fcVJERXhHOWdLMjUzQ3U2dUFjaGZUSmNkVV9na1ZyWU9WOGNjTmI0VjZBQkg2M1ZZcXRyVEZtMHdqd1FsNS1USEw5cEcwRlB1RkJYRFYwNHI0Tk1oSkd6WVZTQTY5Z3lXYUZtRFZXWDdkNnhnOEVLWWxyT3RQRFJoNUN0MlBXcHFIcDVnN1NTdlBKS0FtZUVWWnR6aU5MbnJsREdR?oc=5","Fri, 02 Oct 2026 12:13:18 GMT","Pyxis Oncology closes $110 million public offering By Investing.com Investing.com Nigeria",{"title":271,"link":272,"pubDate":273,"description":274,"source":221},"PYXS 8-K & SEC Filings - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiekFVX3lxTE1OOU5ya2dmUTBfUjZrMzZfMXNvY1R5TnpQT3ZkYzdqSU1YdGJORlQ5QzEydkRBYWxQQnFSM2k5ejNCTGE1Y1k4ZDgxTE1Pb0lDUFp3OE1qeTBPdnpBZzFJWDRnWFlMcjBhU0JjOGJDN0xtTUFoV1htRUpn?oc=5","Thu, 01 Oct 2026 07:00:00 GMT","PYXS 8-K & SEC Filings Yahoo Finance",{"title":276,"link":277,"pubDate":278,"description":279,"source":280},"Pyxis Oncology (PYXS) Slips 2.28% to $2.14 as Shares Test Lower End of Recent Range - Ichimoku Cloud - https:\u002F\u002Fwww.dars.gov.et\u002F","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxNNUo3S05qNk15Y2FsYngyTUdfbXRROXBEbmtVR0tpZEVabUtnNVJlN1hHbDBsZGpMVGxUSTE0YkF4N0ZDRkdEcHhLaU1DejM4bjRHSUdEVjQ1aDc5NUpjTGk0T0xoUUtTM2VwRDlMTjBXcFFHTVQzdlpIek9Ub3poQzdmQ3ptWXBaeERHWnBUUy1PRFhJUUJtOXF2QlZ0NW5EYVhVbW9CUkN6ZTJ4S0lid2ZUeEFtNi14S29V?oc=5","Sat, 03 Oct 2026 14:44:46 GMT","Pyxis Oncology (PYXS) Slips 2.28% to $2.14 as Shares Test Lower End of Recent Range - Ichimoku Cloud https:\u002F\u002Fwww.dars.gov.et\u002F","https:\u002F\u002Fwww.dars.gov.et\u002F",{"title":282,"link":283,"pubDate":284,"description":285,"source":286},"Pyxis Oncology stock fell 9.82 percent on October 6 after financing - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxQZTd1OUs5Z2RTZ1ZHQVRsX1ZmMlVlZ0QtODBTYWh3aVBSSVdhNm1FTlNQTzM3bXlYdkk4bG9YVml0aGdrVHcyYU1pbXl3NlM1N0NYYl9mRGlyRGowMGpmVkJReUY4N3dfYVlMcHFjNkhONnBpazJadXN2ZGl2R1hUZVJ5NjRadG9kVU5tUXBOMUxJcXd5QWlWU0s5WTR2cTNCMW9ydE5WSTQ5SWkwVXFtRWpCVTVWdFFtZjdnM01BSEdhMUZS?oc=5","Tue, 06 Oct 2026 23:22:49 GMT","Pyxis Oncology stock fell 9.82 percent on October 6 after financing AD HOC NEWS","AD HOC NEWS"]